Cargando…
In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model
BACKGROUND AND AIMS: Pluripotent stem cell–derived hepatocytes differentiated in monolayer culture are known to have more fetal than adult hepatocyte characteristics. If numerous studies tend to show that this immature phenotype might not necessarily be an obstacle to their use in transplantation, o...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299628/ https://www.ncbi.nlm.nih.gov/pubmed/34687060 http://dx.doi.org/10.1002/hep.32211 |
_version_ | 1784751018098032640 |
---|---|
author | Luce, Eléanor Steichen, Clara Allouche, Mickaël Messina, Antonietta Heslan, Jean‐Marie Lambert, Thierry Weber, Anne Nguyen, Tuan Huy Christophe, Olivier Dubart‐Kupperschmitt, Anne |
author_facet | Luce, Eléanor Steichen, Clara Allouche, Mickaël Messina, Antonietta Heslan, Jean‐Marie Lambert, Thierry Weber, Anne Nguyen, Tuan Huy Christophe, Olivier Dubart‐Kupperschmitt, Anne |
author_sort | Luce, Eléanor |
collection | PubMed |
description | BACKGROUND AND AIMS: Pluripotent stem cell–derived hepatocytes differentiated in monolayer culture are known to have more fetal than adult hepatocyte characteristics. If numerous studies tend to show that this immature phenotype might not necessarily be an obstacle to their use in transplantation, other applications such as drug screening, toxicological studies, or bioartificial livers are reliant on hepatocyte functionality and require full differentiation of hepatocytes. New technologies have been used to improve the differentiation process in recent years, usually evaluated by measuring the albumin production and CYP450 activity. Here we used the complex production and most importantly the activity of the coagulation factor IX (FIX) produced by mature hepatocytes to assess the differentiation of hemophilia B (HB) patient’s induced pluripotent stem cells (iPSCs) in both monolayer culture and organoids. APPROACH AND RESULTS: Indeed, HB is an X‐linked monogenic disease due to an impaired activity of FIX synthesized by hepatocytes in the liver. We have developed an in vitro model of HB hepatocytes using iPSCs generated from fibroblasts of a severe HB patient. We used CRISPR/Cas9 technology to target the genomic insertion of a coagulation factor 9 minigene bearing the Padua mutation to enhance FIX activity. Noncorrected and corrected iPSCs were differentiated into hepatocytes under both two‐dimensional and three‐dimensional differentiation protocols and deciphered the production of active FIX in vitro. Finally, we assessed the therapeutic efficacy of this approach in vivo using a mouse model of HB. CONCLUSIONS: Functional FIX, whose post‐translational modifications only occur in fully mature hepatocytes, was only produced in corrected iPSCs differentiated in organoids. Immunohistochemistry analyses of mouse livers indicated a good cell engraftment, and the FIX activity detected in the plasma of transplanted animals confirmed rescue of the bleeding phenotype. |
format | Online Article Text |
id | pubmed-9299628 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92996282022-07-21 In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model Luce, Eléanor Steichen, Clara Allouche, Mickaël Messina, Antonietta Heslan, Jean‐Marie Lambert, Thierry Weber, Anne Nguyen, Tuan Huy Christophe, Olivier Dubart‐Kupperschmitt, Anne Hepatology Original Articles BACKGROUND AND AIMS: Pluripotent stem cell–derived hepatocytes differentiated in monolayer culture are known to have more fetal than adult hepatocyte characteristics. If numerous studies tend to show that this immature phenotype might not necessarily be an obstacle to their use in transplantation, other applications such as drug screening, toxicological studies, or bioartificial livers are reliant on hepatocyte functionality and require full differentiation of hepatocytes. New technologies have been used to improve the differentiation process in recent years, usually evaluated by measuring the albumin production and CYP450 activity. Here we used the complex production and most importantly the activity of the coagulation factor IX (FIX) produced by mature hepatocytes to assess the differentiation of hemophilia B (HB) patient’s induced pluripotent stem cells (iPSCs) in both monolayer culture and organoids. APPROACH AND RESULTS: Indeed, HB is an X‐linked monogenic disease due to an impaired activity of FIX synthesized by hepatocytes in the liver. We have developed an in vitro model of HB hepatocytes using iPSCs generated from fibroblasts of a severe HB patient. We used CRISPR/Cas9 technology to target the genomic insertion of a coagulation factor 9 minigene bearing the Padua mutation to enhance FIX activity. Noncorrected and corrected iPSCs were differentiated into hepatocytes under both two‐dimensional and three‐dimensional differentiation protocols and deciphered the production of active FIX in vitro. Finally, we assessed the therapeutic efficacy of this approach in vivo using a mouse model of HB. CONCLUSIONS: Functional FIX, whose post‐translational modifications only occur in fully mature hepatocytes, was only produced in corrected iPSCs differentiated in organoids. Immunohistochemistry analyses of mouse livers indicated a good cell engraftment, and the FIX activity detected in the plasma of transplanted animals confirmed rescue of the bleeding phenotype. John Wiley and Sons Inc. 2021-12-12 2022-04 /pmc/articles/PMC9299628/ /pubmed/34687060 http://dx.doi.org/10.1002/hep.32211 Text en © 2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Luce, Eléanor Steichen, Clara Allouche, Mickaël Messina, Antonietta Heslan, Jean‐Marie Lambert, Thierry Weber, Anne Nguyen, Tuan Huy Christophe, Olivier Dubart‐Kupperschmitt, Anne In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model |
title | In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model |
title_full | In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model |
title_fullStr | In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model |
title_full_unstemmed | In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model |
title_short | In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model |
title_sort | in vitro recovery of fix clotting activity as a marker of highly functional hepatocytes in a hemophilia b ipsc model |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299628/ https://www.ncbi.nlm.nih.gov/pubmed/34687060 http://dx.doi.org/10.1002/hep.32211 |
work_keys_str_mv | AT luceeleanor invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel AT steichenclara invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel AT allouchemickael invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel AT messinaantonietta invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel AT heslanjeanmarie invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel AT lambertthierry invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel AT weberanne invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel AT nguyentuanhuy invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel AT christopheolivier invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel AT dubartkupperschmittanne invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel |